Rajkumar Kaushik Vishnu, Lakshmanan Ganesh, Sekar Durairaj
Department of Anatomy, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai 600077, India.
Dental Research Cell and Biomedical Research Unit (DRC-BRULAC), Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai 600077, India.
World J Diabetes. 2020 Dec 15;11(12):567-571. doi: 10.4239/wjd.v11.i12.567.
MicroRNAs (miRNA) are recently discovered endogenous, small noncoding RNAs (of 22 nucleotides) that play pivotal roles in gene regulation. They are involved in post-transcriptional control of gene expression. miRNAs are emerging as important regulators of cell proliferation, development, cancer formation, stress responses, cell death and physiological conditions. Increasing evidence has demonstrated the human miRNAs bind to their target mRNA sequences with perfect or near-perfect sequence complementarily. This provides a powerful strategy for discovering potential type 2 diabetes mellitus (T2DM) targets and gives the probability to exploit them for diagnostic and therapeutic causes. About 6% of the world population is affected by T2DM, and it is recognized as a global epidemic by the World Health Organization. At present there is no valid biomarker to control or manage T2DM. Therefore, the present study applied a mature sequence of miRNAs from publicly accessible databases to identify the miRNA from T2DM expressed sequence tags, and the results are detailed and discussed below.
微小RNA(miRNA)是最近发现的内源性小非编码RNA(22个核苷酸),在基因调控中起关键作用。它们参与基因表达的转录后控制。miRNA正成为细胞增殖、发育、癌症形成、应激反应、细胞死亡和生理状况的重要调节因子。越来越多的证据表明,人类miRNA与其靶mRNA序列以完美或近乎完美的序列互补性结合。这为发现潜在的2型糖尿病(T2DM)靶点提供了有力策略,并为将其用于诊断和治疗目的提供了可能性。世界约6%的人口受T2DM影响,世界卫生组织将其认定为全球流行病。目前尚无有效的生物标志物来控制或管理T2DM。因此,本研究应用来自公开数据库的成熟miRNA序列,从T2DM表达序列标签中鉴定miRNA,结果详述如下。